ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Moffitt Gets $100M From Fla. For Construction; Two Head And Neck Surgical Societies Merge

July 3, 1998

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009